Is blood or bone marrow betterxs?

Anne Kessinger

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Hemalopoiesis that has been ablated with high‐dose radiation‐chemotherapy can be restored with either autologous peripheral stem cell transplantation (PSCT) or autologous bone marrow transplantation (ABMT). Characteristics unique to either type of transplant make one preferable to the other in certain clinical situations. When marrow metastases preclude ABMT, blood provides a suitable source of precursors for autografting. Peripheral cells are more time consuming to collect and more labor intensive to process and store. The peripheral autograft product can be manipulated with mobilization techniques (chemotherapy and/or cytokines) to provide more rapid recovery of granulocytes and perhaps red cells and platelets, while transplantation of manipulated marrow autografts has not yet been reported. Further advances in both ABMT and PSCT will provide additional opportunities to improve the outcome of patients treated with high‐dose therapy.

Original languageEnglish (US)
Pages (from-to)290-295
Number of pages6
Issue number4
StatePublished - 1993


  • Bone marrow transplantation
  • Peripheral stem cells

ASJC Scopus subject areas

  • Molecular Medicine
  • Developmental Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Is blood or bone marrow betterxs?'. Together they form a unique fingerprint.

Cite this